Summary of the updated international consensus diagnostic criteria for eosinophilic esophagitis: AGREE conference

participants of AGREE

Research output: Contribution to journalArticlepeer-review

67 Scopus citations
Original languageEnglish (US)
Pages (from-to)281-284
Number of pages4
JournalAnnals of Allergy, Asthma and Immunology
Volume121
Issue number3
DOIs
StatePublished - Sep 2018

Funding

Funding Sources: This study was funded by the International Gastrointestinal Eosinophilic Diseases Researchers; the David and Denise Bunning Family; grant U54AI117804 (Consortium of Eosinophilic Gastrointestinal Disease Researchers), which is part of the Rare Disease Clinical Research Network, an initiative of the Office of Rare Disease Research, National Center for Advancing Translational Sciences, and is funded through collaboration of National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences, and patient advocacy groups, including American Partnership for Eosinophilic Disorders, Campaign Urging Research for Eosinophilic Disease, and Eosinophilic Family Coalition (Drs. Spergel, Furuta, Liacouras, Dellon and Hirano); and grant K24DK100303 from the National Institutes of Health (Dr. Furuta). Disclosures: Dr Spergel reported working as a consultant for Regeneron, DBV Technology, and Kaleo; receiving grants from DBV Technology, Aimmune Therapeutics, and Food Allergy Research Education; and receiving royalities from UpToDate Dr Dellon reported working as a consultant for Adare, Allakos, Alivio, Banner, Celgene/Receptos, Enumeral, GSK, Regeneron, and Shire; receiving research funding from Adare, Celgene/Receptos, Miraca, Meritage, Nutricia, Regeneron, and Shire; and receiving educational grants from Banner and Holoclara. Dr Liacouras reported working as a consultant for Shire, Adare, Abbott Nutrition, Receptos, and TEVA. Dr Hirano reported working as a consultant for Adare and Allakos. Dr Molina-Infante reported receiving research funding and working as a consultant for Dr. Falk Pharma. Dr Furuta reported being a founder of EnteroTrack, working as a consultant for Shire, and receiving royalties from UpToDate.

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Immunology and Allergy
  • Immunology

Cite this